Tiroch Klaus, Cannon Louis, Reisman Mark, Caputo Ronald, Caulfield Todd, Heuser Richard, Braden Greg, Low Reginald, Stone Gregg, Almonacid Alexandra, Popma Jeffrey J
Cardiovascular Division, Department of Internal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Catheter Cardiovasc Interv. 2008 Nov 15;72(6):771-80. doi: 10.1002/ccd.21693.
Recanalization of coronary chronic total occlusions (CTOs) remains a clinical challenge, particularly when standard guidewire attempts fail.
We sought to determine the safety and efficacy of a novel method that used high-frequency (20 kHz) vibration to fragment occlusive fibrous tissue and facilitate guidewire crossing into the distal vessel.
A total of 125 patients with CTO, who failed at attempts of conventional guidewire recanalization after more than 5 min of fluoroscopy time, were enrolled in the study. The primary efficacy endpoint was the advancement of the CROSSER catheter through the occlusion and attainment of coronary guidewire positioning in the distal coronary lumen. The primary safety endpoint was the occurrence of death, myocardial infarction, clinical perforation, or target vessel revascularization within the first 30 days.
The average fluoroscopy time while delivering the CROSSER catheter was 12.4 min. CROSSER-assisted guidewire recanalization was achieved in 76 (60.8%) procedures and a final diameter stenosis <50% was obtained in 68 (54.4%) of cases. Major adverse events occurred in 11 (8.8%) patients, lower than the predefined objective performance criteria. Angina frequency and quality of life were improved in patients with successful guidewire recanalization.
We conclude that high-frequency vibration using the CROSSER catheter is a safe and effective therapy for patients with CTO, which are refractory to standard guidewire recanalization.
冠状动脉慢性完全闭塞(CTO)的再通仍然是一项临床挑战,尤其是在标准导丝尝试失败时。
我们试图确定一种使用高频(20 kHz)振动来破碎闭塞性纤维组织并促进导丝穿过进入远端血管的新方法的安全性和有效性。
共有125例CTO患者纳入本研究,这些患者在透视时间超过5分钟的常规导丝再通尝试中失败。主要疗效终点是CROSSER导管穿过闭塞病变并将冠状动脉导丝定位在远端冠状动脉管腔内。主要安全终点是在最初30天内发生死亡、心肌梗死、临床穿孔或靶血管血运重建。
输送CROSSER导管时的平均透视时间为12.4分钟。76例(60.8%)手术实现了CROSSER辅助导丝再通,68例(54.4%)病例最终直径狭窄<50%。11例(8.8%)患者发生了主要不良事件,低于预先定义的客观性能标准。导丝再通成功的患者心绞痛频率和生活质量得到改善。
我们得出结论,对于标准导丝再通无效的CTO患者,使用CROSSER导管进行高频振动是一种安全有效的治疗方法。